We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In an en banc opinion, Therasense, Inc. v. Becton, Dickinson & Co., the Federal Circuit decried the effect of the inequitable conduct doctrine on the patent system and issued tightened evidentiary standards for satisfying that doctrine
